ArticleFrontiers in immunology2025

IL-17A drives a fibroblast-neutrophil-NET axis to exacerbate immunopathology in the lung with diffuse alveolar damage.

Duo Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.